Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 190
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01331525 | The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer | ||
| NCT02170415 | Development of a Personalised Care Plan Designed to Reduce Chronic Post-Operative Pain Following Breast Surgery | ||
| NCT02389842 | PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclib | ||
| NCT02305654 | International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study) | ||
| NCT04270799 | Lung Nodule Imaging Biobank for Radiomics and AI Research | ||
| NCT01395121 | A Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread | ||
| NCT03621332 | HRQoL in Advanced Soft Tissue Sarcoma Patients Treated With Chemotherapy. | ||
| NCT02757651 | KORTUC: Intra-tumoural Hydrogen Peroxide as a Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer in Terms of Toxicity and Tumour Response | ||
| NCT00867347 | Radiation Therapy or Surgery in Treating Patients Receiving Chemotherapy for Bladder Cancer | ||
| NCT02587455 | Pembrolizumab and Palliative Radiotherapy in Lung | ||
| NCT05810467 | The Active Surveillance Study | ||
| NCT04842799 | Digital Delivery of Information About Genetic Testing for Breast Cancer | ||
| NCT06636526 | The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study). | ||
| NCT06976892 | Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer | ||
| NCT01567137 | MR Characterisation/Localisation of Breast Cancer | ||
| NCT00578240 | Molecular Studies and Clinical Correlations in Human Prostatic Disease | ||
| NCT01977638 | Phase 1 Trial of CXD101 in Patients With Advanced Cancer | ||
| NCT02705846 | Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations | ||
| NCT03479151 | Magnetic Resonance Guided High Intensity Focused Ultrasound (MRgHIFU) for Pain Palliation of Bone Metastases | ||
| NCT01881386 | Lactate Imaging as a Tumour Biomarker | ||
| NCT00532727 | Triple Negative Breast Cancer Trial | ||
| NCT03256981 | Stereotactic Body Radiotherapy for the Treatment of OPD | ||
| NCT06632236 | 5G-EMERALD: Amivantamab in Malignant Brain Tumours | ||
| NCT03795272 | Rucaparib Maintenance Therapy in Advanced Cervical Cancer | ||
| NCT07718243 | Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC | ||
| NCT02375204 | Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors | ||
| NCT02973828 | PRIMER: Development of Daily Online Magnetic Resonance Imaging for Magnetic Resonance Image Guided Radiotherapy | ||
| NCT03262311 | Pimo Study: Extracellular Vesicle-based Liquid Biopsy to Detect Hypoxia in Tumours | ||
| NCT02388308 | Evaluation of Clarity Ultrasound Guidance for Prostate Therapy | ||
| NCT02360345 | Phase I Trial of ONX-0801 Once Weekly or Alternate Weekly | ||
| NCT03740893 | PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast Cancer | ||
| NCT03182634 | The UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) Trial | ||
| NCT02057913 | A Phase II Trial of Vinflunine Chemotherapy in Locally-advanced and Metastatic Carcinoma of the Penis (VinCaP) | ||
| NCT06396754 | Deployment and Clinical Evaluation of an AI-powered Digital Oncology Biomarker Tool to guidE Treatment in TNBC | ||
| NCT01332968 | A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM) | ||
| NCT05782361 | POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC | ||
| NCT00997464 | An Exploration of Genetic Testing for Prostate Cancer Susceptibility | ||
| NCT05368298 | SCOOT: Sample Collection for DART | ||
| NCT02819752 | PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck | ||
| NCT00077168 | Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole | ||
| NCT07002320 | Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer | ||
| NCT00301925 | Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery | ||
| NCT04901468 | A-EYE: A Mixed Quantitative and Qualitative Study to Develop and Evaluate the Application of Artificial Intelligence (AI) Methods Using Retinal Imaging for the Identification of Adverse Retinal Changes Associated With Cancer Therapies. | ||
| NCT05533190 | Clinical Investigation of Wysa | ||
| NCT07529418 | The BALANCE Study: BlAck and Mixed Men's Lived Experience With Prostate cANCEr-Diversity in Prostate Cancer PROMS Study | ||
| NCT04084145 | National Unified Renal Translation Research Enterprise - Chronic Kidney Disease | ||
| NCT03177187 | Combination Study of AZD5069 and Enzalutamide. | ||
| NCT00248521 | 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) in Treating Patients With Metastatic Solid Tumors or Tumors That Cannot Be Removed By Surgery | ||
| NCT04458311 | Abiraterone Acetate in Combination With Tildrakizumab | ||
| NCT01101438 | A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer |
